Oculis’ Post

View organization page for Oculis, graphic

3,960 followers

Dry Eye Awareness Month highlights this prevalent disease affecting nearly 40 million people in the United States alone and can lead to ocular discomfort, fatigue, and visual disturbances, significantly impacting their quality of life. A recent report showed that the vast majority of patients (87%) don’t feel that their chronic dry eye disease is well-managed with current treatment options. As a company focused on saving sight and improving eye care, we are committed to advancing innovative treatments for diseases such as DED. To learn more, check out this recent Q&A in @Healio with Riad SHERIF, MD, our CEO, and Dr. Anat Galor, Professor of Ophthalmology at the Bascom Palmer Eye Institute, University of Miami, discussing the recent positive topline results from the phase 2b RELIEF trial with licaminlimab, Oculis’ novel anti-TNF-α eye drop, and highlighting the Company’s #PrecisionMedicine approach that has the potential to transform the current treatment paradigm for DED: https://lnkd.in/evsRQXMJ   #Ophthalmology #DryEyeAwarenessMonth #DryEye #EyeHealth #Biotech

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics